中国医药科学2016，Vol.6Issue(14)：46-48,51,4.
低分子肝素在慢性阻塞性肺疾病急性加重期合并呼吸衰竭的治疗作用
Effect of low molecular weight heparin in the treatment of acute exacerbation combined with respiratory failure of chronic obstructive pulmonary disease
曾建红 1曾军 2李越利 1梁健欣1
作者信息
- 1. 广州市第一人民医院鹤洞分院呼吸内科，广东广州 510380
- 2. 广州市第一人民医院，广东广州，510180
- 折叠
摘要
Abstract
Objective To explore the clinical effect of low molecular weight heparin in the treatment of patients with acute exacerbation combined with respiratory failure of chronic obstructive pulmonary disease.Methods 100 cases of this kind of patients cured in our hospital were selected as the study objects and were divided into two groups with 50 cases in each.Patients in control group were treated with routing therapy,and patients in study group were treated with subcutaneous injection of low molecular weight heparin on the basis of routine therapy.The clinical effects of the two groups were compared.ResultsClinical treatment efficiency of study group was up to 92.00%,which was significantly higher than that of control group with 66.0% (P<0.05).Average length of stay of study group was significantly less than that of control group.Improvement of coagulation function and D-two polymer reduction level after completing the therapy of study group were significantly better than those of control group (P<0.05).Conclusion Low molecular weight heparin in the treatment of acute exacerbation combined with respiratory failure of chronic obstructive pulmonary disease can achieve significant results,and it can effectively alleviate the patient’s condition and reduce the inflammatory reaction.It has a positive effect on the control of disease progression,and it has great popularization and application value.关键词
低分子肝素/慢性阻塞性肺疾病/急性加重期/呼吸衰竭/疗效Key words
Low molecular weight heparin/Chronic obstructive pulmonary disease/Acute exacerbation/Respiratory failure/Curative effect分类
医药卫生引用本文复制引用
曾建红,曾军,李越利,梁健欣..低分子肝素在慢性阻塞性肺疾病急性加重期合并呼吸衰竭的治疗作用[J].中国医药科学,2016,6(14):46-48,51,4.
